Independent research • Source-backed profiles • No paid rankings
Peptide Provider Direct
RxPepsDirect logo
License information checked7 services cataloged

RxPepsDirect

Virtual provider · Telehealth available

Visit provider website ↗

Provider overview

About RxPepsDirect

RxPepsDirect is a direct-to-consumer telehealth platform whose official site identifies Jonathan Snipes, MD, as medical director and publishes a 29-jurisdiction service list. Its catalog advertises metabolic, growth-hormone-related, recovery, longevity, cognitive, and sexual-health peptide protocols. The active CMS NPI record supports Dr. Snipes's physician identity and multiple state licenses, but it does not independently establish every jurisdiction claimed by the platform; coverage below is therefore provider-reported. Many catalog items have compounded, investigational, unapproved, or otherwise unclear regulatory and availability status. This profile does not infer a pharmacy classification, product sourcing, formulation, legal availability, safety, or effectiveness.

At a glance

Market role
Telehealth platform / connector
Care model
Telehealth
Coverage
29 listed jurisdictions
Pharmacy pathway
Not publicly established
Medical weight managementHormone healthLongevity medicineMetabolic healthRecovery support

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Provider-advertised services, grouped for quick scanning with all details visible.

7 cataloged
01

GLP-1 and metabolic programs

1

Semaglutide- and tirzepatide-related programs

The platform advertises these active ingredients; eligibility, formulation, indication, regulatory status, and availability require clinician confirmation.

Provider source ↗
02

Peptide-related care

1

Sermorelin, CJC-1295, and ipamorelin protocols

These growth-hormone-related compounds are provider-advertised; regulatory status and current availability are not independently established.

Provider source ↗
03

Recovery services

1

BPC-157, TB-500, and KPV protocols

These recovery-oriented catalog items are provider-advertised and may be investigational, unapproved, compounded, or unavailable; no outcome claim is adopted.

Provider source ↗
04

Longevity programs

1

NAD+ and MOTS-C programs

The platform advertises longevity-oriented protocols; product status, sourcing, and availability require confirmation.

Provider source ↗
05

Additional services

1

Cognitive and focus catalog

The provider lists cognitive-oriented peptide options; this profile does not endorse or independently validate the promoted uses.

Provider source ↗
06

Sexual health

1

PT-141 sexual-health program

PT-141 is listed by the provider; eligibility, indication, formulation, and current availability require clinician confirmation.

Provider source ↗
07

Care model

1

Remote clinician review

The platform describes online intake, clinician review, and follow-up across its provider-reported service jurisdictions.

Provider source ↗
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Coverage and research

Explore this provider’s markets

Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.

AlaskaArizonaColoradoConnecticutDelawareDistrict of ColumbiaFloridaIdahoIllinoisIndianaIowaKansasLouisianaMaineMichiganMontanaNevadaNew HampshireNew JerseyNew YorkNorth DakotaPennsylvaniaRhode IslandTexasUtahVermontWashingtonWisconsinWyoming
Sermorelin research guide →Lab testing in peptide programs →Researching longevity claims →

Continue comparing

Related provider profiles

Advanced Spine and Pain ClinicsAnderson Longevity ClinicAnti-Aging Northwest

Evidence

Sources reviewed

Logo reproduced from the provider’s official website for identification. Logo source ↗

These links support the public facts recorded here. Provider-published information is not an independent endorsement.